Literature DB >> 6280134

Construction and partial characterization of two recombinant cDNA clones for procollagen from chicken cartilage.

E Vuorio, L Sandell, D Kravis, V C Sheffield, T Vuorio, A Dorfman, W B Upholt.   

Abstract

Type II procollagen mRNA has been partially purified from embryonic chick sternal cartilage by guanidine hydrochloride extraction, sucrose gradient sedimentation and Sepharose 4B chromatography. Double stranded cDNA was synthesized using AMV reverse transcriptase and E. coli DNA polymerase I, tailed using terminal transferase and inserted into the Pst I site of pBR322. Two putative type II procollagen cDNA clones have been characterized. Both plasmids hybridize to 2 sternal RNA species, a major species of 5.3 kb and a minor species of 7 kb. These RNAs are present in total RNA from sterna and differentiated limb bud cultures but are not detected in RNA from stage 24 limb bud which has not yet differentiated to cartilage or in RNA from calvaria. The time of appearance of these RNAs during the differentiation of limb mesenchyme in culture parallels the appearance of translatable type II procollagen mRNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280134      PMCID: PMC320517          DOI: 10.1093/nar/10.4.1175

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation.

Authors:  B M Paterson; B E Roberts; E L Kuff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 2.  Biosynthesis of procollagen.

Authors:  J H Fessler; L I Fessler
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

3.  Calcium-dependent bacteriophage DNA infection.

Authors:  M Mandel; A Higa
Journal:  J Mol Biol       Date:  1970-10-14       Impact factor: 5.469

4.  Study of differential collagen synthesis during development of the chick embryo by immunofluroescence. II. Localization of type I and type II collagen during long bone development.

Authors:  K von der Mark; H von der Mark; S Gay
Journal:  Dev Biol       Date:  1976-10-15       Impact factor: 3.582

5.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

6.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Procollagen complementary DNA, a probe for messenger RNA purification and the number of type I collagen genes.

Authors:  A M Frischauf; H Lehrach; C Rosner; H Boedtker
Journal:  Biochemistry       Date:  1978-08-08       Impact factor: 3.162

9.  Synthesis of double-stranded DNA complementary to lysozyme, ovomucoid, and ovalbumin mRNAs. Optimization for full length second strand synthesis by Escherichia coli DNA polymerase I.

Authors:  M P Wickens; G N Buell; R T Schimke
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

10.  Immunological and biochemical studies of collagen type transition during in vitro chrondrogenesis of chick limb mesodermal cells.

Authors:  K von der Mark; H von der Mark
Journal:  J Cell Biol       Date:  1977-06       Impact factor: 10.539

View more
  17 in total

1.  Isolation and partial characterization of the entire human pro alpha 1(II) collagen gene.

Authors:  F O Sangiorgi; V Benson-Chanda; W J de Wet; M E Sobel; P Tsipouras; F Ramirez
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

2.  Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation.

Authors:  E S Allebach; D Boettiger; M Pacifici; S L Adams
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

3.  Collagen gene expression by cultured human skin fibroblasts. Abundant steady-state levels of type VI procollagen messenger RNAs.

Authors:  D R Olsen; J Peltonen; S Jaakkola; M L Chu; J Uitto
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

4.  Discrimination among multiple AATAAA sequences correlates with interspecies conservation of select 3' untranslated nucleotides.

Authors:  J C Myers; J M Brinker; N A Kefalides; J Rosenbloom; S Y Wang; L J Gudas
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

5.  Primary structure of the telopeptide and a portion of the helical domain of chicken type II procollagen as determined by DNA sequence analysis.

Authors:  F Deák; W S Argraves; I Kiss; K J Sparks; P F Goetinck
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

6.  In situ hybridisation study of type I, II, X collagens and aggrecan mRNas in the developing condylar cartilage of fetal mouse mandible.

Authors:  K Fukada; S Shibata; S Suzuki; K Ohya; T Kuroda
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

7.  Isolation of cDNA and genomic DNA clones encoding type II collagen.

Authors:  M F Young; G Vogeli; A M Nunez; M P Fernandez; M Sullivan; M E Sobel
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

8.  Multiple 3' ends of the chicken pro alpha 2(I) collagen gene.

Authors:  S Aho; V Tate; H Boedtker
Journal:  Nucleic Acids Res       Date:  1983-08-25       Impact factor: 16.971

9.  Tissue specificity of type I collagen gene expression is determined at both transcriptional and post-transcriptional levels.

Authors:  R J Focht; S L Adams
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

10.  Isolation and characterization of genomic clones corresponding to the human type II procollagen gene.

Authors:  C M Strom; W B Upholt
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.